- Home
- DOMO vs NVCT Comparison
DOMO vs NVCT Comparison
Compare DOMO & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOMO | NVCT |
|---|---|---|
| Founded | 2010 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.3M | 220.0M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DOMO | NVCT |
|---|---|---|
| Price | $4.22 | $8.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $12.61 | ★ $15.33 |
| AVG Volume (30 Days) | ★ 1.2M | 49.7K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $317,044,000.00 | N/A |
| Revenue This Year | $2.29 | N/A |
| Revenue Next Year | $2.90 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.45 | $5.55 |
| 52 Week High | $18.49 | $11.52 |
Technical Indicators
Market Signals| Indicator | DOMO | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 42.31 | 57.48 |
| Support Level | N/A | $8.01 |
| Resistance Level | $6.62 | $9.20 |
| Average True Range (ATR) | 0.37 | 0.39 |
| MACD | 0.17 | 0.01 |
| Stochastic Oscillator | 73.09 | 75.00 |
Price Performance
Historical ComparisonAbout DOMO Domo Inc. Class B
Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.